Molecular Imaging

ITM secures U.S. FDA fast-track designation for kidney cancer PET agent

By AuntMinnie.com staff writers

Along with the radiotherapeutic compound ITM-91, the two make up a peptide-based theranostic pair.

November 17, 2025

IAEA recommends global adoption of PSMA-PET

By Will Morton

The finding follows a trial involving 775 men with high-risk prostate cancer across 11 countries with varied income levels.

November 14, 2025

SNMMI issues position paper on RPT

By AuntMinnie.com staff writers

Radiopharmaceutical therapy (RPT) is a rapidly growing form of precision cancer treatment.

November 12, 2025

PSMA-PET effective for initial staging of prostate cancer

By Will Morton

Upfront PSMA-PET/CT has a significant impact on treatment decision-making in men with suspected disease.

November 10, 2025

PSMA-PET visualizes treatment response in liver cancer

By Will Morton

Three radiologists reading PSMA-PET scans agreed almost perfectly on how patients responded to treatment.

November 6, 2025

FDG-PET/CT detects metastatic eye tumors

By Will Morton

F-18 FDG-PET/CT could play a crucial role in a group with low survival rates after metastases.

October 30, 2025

Sirona gets FDA nod for advanced imaging suite

By AuntMinnie.com staff writers

Sirona Medical has received U.S. FDA clearance for the Sirona Advanced Imaging Suite, which expands PET/CT support.

October 30, 2025

Global initiative to guide NMTs in theranostics

By AuntMinnie.com staff writers

The responsibilities of nuclear medicine technologists (NMTs) in theranostics are evolving rapidly.

October 29, 2025

FDA accepts NDA for Lantheus’ PET tracer

By AuntMinnie.com staff writers

The U.S. FDA has accepted a New Drug Application (NDA) for Lantheus’ MK-6240 tau PET imaging tracer.

October 28, 2025

LLMs rapidly evolving in nuclear medicine

By Will Morton

Large language models (LLMs) are widely used to handle the large volume of text data generated in nuclear medicine.

October 24, 2025

PSMA-PET may require selective use to be cost-effective

By Will Morton

Yale University researcher developed a decision-analytic model to estimate lifetime cost outcomes associated with PSMA-PET.

October 24, 2025

Telix's Zircaix included in society guidelines for renal imaging

By AuntMinnie.com staff writers

Telix welcomes updated guidelines from medical societies for including TLX250-CDx (Zircaix) for imaging renal masses.

October 23, 2025

Page 1 of 616

Next Page